KO vs PEP: Coca-Cola Is the Pure Play, PepsiCo Is the Conglomerate
These two have been compared for 60 years, but they're not the same kind of investment. Coca-Cola is the focused beverage company — beverages, mostly non-alcoholic, in 200+ countries. PepsiCo is a food and beverage conglomerate where Frito-Lay (Doritos, Lays, Cheetos) accounts for a quarter of revenue and a larger share of profit. If you're buying PEP, you're buying snacks as much as beverages. Berkshire Hathaway chose KO — not PEP — as its consumer staples anchor. That decision reflects something about business model clarity.
Coca-Cola's Franchise Model Creates Extraordinary Capital Efficiency
Coca-Cola doesn't bottle its own drinks — it manufactures concentrate and sells it to independent bottling partners globally. Those partners invest capital in bottling plants, trucks, and distribution. Coca-Cola collects the high-margin concentrate revenue without tying up capital in physical assets. It's one of the most capital-efficient business models in consumer goods, and it's why Coca-Cola can earn 40%+ return on equity while operating in 200+ countries.
PepsiCo's model is more complex. It owns more of its bottling and distribution infrastructure than Coke does, and Frito-Lay requires significant manufacturing assets. PEP is a more capital-intensive business than KO, which is partly why PepsiCo's margins have historically been somewhat lower than Coca-Cola's despite comparable scale.
Business Comparison
- 200+ country distribution network
- Asset-light concentrate model
- Berkshire Hathaway core holding since 1988
- Sparkling + still + energy (Monster stake)
- 62+ years consecutive dividend increases
- Frito-Lay: Doritos, Lays, Cheetos, Fritos
- Quaker: oats, cereals, nutrition bars
- Beverages: Pepsi, Gatorade, Mountain Dew
- More vertically integrated than KO
- 50+ years consecutive dividend increases
GLP-1 Drugs: The New Consumer Staples Risk Factor
Both KO and PEP face the GLP-1 question — if millions of people on Ozempic and Wegovy are consuming fewer calories, does that structurally reduce demand for carbonated beverages and salty snacks? The evidence so far is mixed. GLP-1 users do show reduced consumption of sugary and salty foods, but the scale of affected consumers is still small relative to total market volume.
PEP faces more acute near-term GLP-1 risk because Frito-Lay products are classic "impulse snack" categories that GLP-1 drugs specifically reduce craving for. KO's beverages are more drink-occasion driven and slightly less at risk from appetite-suppressing drugs. This is a slow-moving headwind to watch over 5-10 years, not a near-term earnings disruption.
Who Should Buy Which
Technical Signals — What to Watch
KO and PEP are slow-moving defensive names that lag in bull markets and hold well in corrections. Their technical signals are most useful for timing entries.
- RSI: Both rarely get to RSI extremes. Dips to RSI 40-45 during market corrections or rate-hike fears are historically reliable buying opportunities for long-term holders. Avoid adding when RSI is above 65 — these stocks mean-revert.
- MACD: Weekly MACD crossovers on KO and PEP signal intermediate-term trend changes. Both stocks respond to inflation data, interest rate expectations (their dividends compete with bonds), and consumer spending reports.
- Volume: Watch for institutional rotation into consumer staples during equity market volatility — this shows up as above-average volume in KO and PEP on days when the broader market sells off.
APEX scores both stocks daily across RSI, MACD, moving averages, volume, and 52-week position. Updated every market day.
Compare KO vs PEP Live →